Patents by Inventor Jaume COLL CANTÍ

Jaume COLL CANTÍ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREDICTION OF THE OUTCOME OF ENDOVASCULAR TREATMENT IN ACUTE ISCHEMIC STROKE PATIENTS
    Publication number: 20230414169
    Abstract: The present application provides for use of a somatosensory evoked potential (SEP) during the hyperacute stroke phase as marker for predicting the outcome of endovascular treatment in a patient suffering from acute ischemic stroke, wherein when the SEP ipsilateral to the stroke site has an amplitude from 60% to 100% with respect to the corresponding SEP contralateral to the stroke site this is indicative of good outcome of the endovascular treatment, whereas when the SEP ipsilateral to the stroke site has an amplitude from 0% to 20% with respect to the corresponding SEP contralateral to the stroke site this is indicative of bad outcome of the endovascular treatment.
    Type: Application
    Filed: April 14, 2023
    Publication date: December 28, 2023
    Applicant: FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL
    Inventors: Alicia MARTÍNEZ PIÑEIRO, Jaume COLL CANTÍ
  • Prediction of the outcome of endovascular treatment in acute ischemic stroke patients
    Patent number: 11653866
    Abstract: The present application provides for use of a somatosensory evoked potential (SEP) during the hyperacute stroke phase as marker for predicting the outcome of endovascular treatment in a patient suffering from acute ischemic stroke, wherein when the SEP ipsilateral to the stroke site has an amplitude from 60% to 100% with respect to the corresponding SEP contralateral to the stroke site this is indicative of good outcome of the endovascular treatment, whereas when the SEP ipsilateral to the stroke site has an amplitude from 0% to 20% with respect to the corresponding SEP contralateral to the stroke site this is indicative of bad outcome of the endovascular treatment.
    Type: Grant
    Filed: February 16, 2018
    Date of Patent: May 23, 2023
    Assignee: FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL
    Inventors: Alicia Martínez Piñeiro, Jaume Coll Cantí
  • PREDICTION OF THE OUTCOME OF ENDOVASCULAR TREATMENT IN ACUTE ISCHEMIC STROKE PATIENTS
    Publication number: 20200113462
    Abstract: The present application provides for use of a somatosensory evoked potential (SEP) during the hyperacute stroke phase as marker for predicting the outcome of endovascular treatment in a patient suffering from acute ischemic stroke, wherein when the SEP ipsilateral to the stroke site has an amplitude from 60% to 100% with respect to the corresponding SEP contralateral to the stroke site this is indicative of good outcome of the endovascular treatment, whereas when the SEP ipsilateral to the stroke site has an amplitude from 0% to 20% with respect to the corresponding SEP contralateral to the stroke site this is indicative of bad outcome of the endovascular treatment.
    Type: Application
    Filed: February 16, 2018
    Publication date: April 16, 2020
    Inventors: Alicia MARTÍNEZ PIÑEIRO, Jaume COLL CANTÍ